Use of AI-driven care for patients with type 1 diabetes has freed up clinicians’ time to focus on patients’ quality of life and provide more empathic, patient-centered care.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
A.N. has served as advisor and received consulting fees from Roche, Sanofi, Medtronic, Eli Lilly, Steady Health, and Intuity Medical, has served as unpaid advisor for Tidepool, has received research grants from Eli Lilly, Pfizer, Royal Philips, Commonwealth Fund and Cisco, and has received author and speaker honoraria from TCOYD, The Doctors Company, Medscape/WebMD and AcademyHealth.
Rights and permissions
About this article
Cite this article
Neinstein, A.B. Our AI future is better than you think. Nat Med 28, 2254 (2022). https://doi.org/10.1038/s41591-022-02021-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-022-02021-9
